T
he maturation of conventional ␣␤ T cells relies on the interaction of their T cell antigen receptor (TCR) with self-major histocompatibility complex (MHC) molecules presenting self-peptides in the thymus. This interaction either rescues immature thymocytes from apoptosis and signals them to complete their maturation (positive selection), or causes their deletion by precipitating apoptosis (negative selection). These opposed outcomes ensure the generation of a highly diverse mature TCR repertoire that is tolerant to virtually all thymic self-determinants (1) (2) (3) (4) . The recognition of self-peptide͞self-MHC complexes is inherent to negative selection. In contrast, the nature of the TCR-MHC interaction involved in positive selection has been a matter of discussion (5) (6) (7) . Early studies using natural mutations affecting MHC class I amino acid residues important for peptide binding but not for TCR-MHC interaction (8, 9) and in vitro studies using fetal thymic organ culture (FTOC) from wild-type or TCR transgenic (Tg) MHC class I deficient mice (10) (11) (12) (13) (14) (15) indicated that self-peptide recognition does have a role in the positive selection of CD8 ϩ T cells. For a given TCR, positive selection can be supported by peptides with minor or no change compared with the antigenic peptide. However, CD8 ϩ T cells selected in the presence of agonist peptides displayed an altered coreceptor expression level and were functionally deficient (16) .
The role of self-peptides in the positive selection of MHC class II-restricted T cells was studied mostly by using mice with a defect in the antigen processing and͞or presentation pathway. Mice deficient in the peptide exchange factor H-2 M (H-2M␣ Ϫ/Ϫ ; refs. [17] [18] [19] and mice expressing only the E␣52-68͞ I-A b complex (I-Ab-Ep; refs. 20 and 21) revealed that when thymic stromal cells express one or a few peptide͞MHC class II complexes, only a quarter to a half of the normal CD4 ϩ T cell numbers is detected in the periphery. Many of these CD4 ϩ T cells indeed differ from normal CD4 ϩ T cells because they react to syngeneic antigen-presenting cells (APCs). In addition, seven distinct CD4 ϩ T cell specificities that develop within a wild-type thymus fail to do so in H-2M␣ Ϫ/Ϫ mice (22) (23) (24) (25) (26) . Maturation of ; ref. 27 ) or mice where a single peptide occupies more than 95% of all MHC class II molecules (28) . The restriction of the parental ␣-chain junction in mature thymocytes from single ␤-chain TCR Tg mice (29) and the blockade of positive selection of CD4 T cells by peptide͞MHC class II specific mAbs in vivo (26, 30) provide additional evidence for the peptide specificity of positive selection of CD4 T cells. Despite the fact that fewer CD4 ϩ T cells are positively selected in I-Ab-Ep and H-2M␣ Ϫ/Ϫ mice, they displayed an apparently diverse TCR repertoire, indicating that positive selection may be more promiscuous than suggested for CD8 T cells. The adenovirus-mediated delivery of invariant chain (Ii)-peptide-fusion proteins in the thymus also revealed that whereas the selection of the moth cytochrome c (MCC)-specific TCR repertoire was peptide-specific, positive selection seemed promiscuous. MCCspecific T cells could be positively selected by the MCC peptide itself, close analogs, or unrelated peptides (31, 32) .
Thus, whereas many lines of evidence now support the importance of self-peptide͞self-MHC complex recognition in positive selection, the degeneracy of such recognition, the structural relationship between the selecting and the antigenic ligands and their potential physiological consequences remain less well de- mAb Treatment of Newborn Mice. Newborn mice were genotyped by PCR on day 1 by using tail genomic DNA. Starting on day 2, animals were intraperitoneally injected with 50 g of purified Y17 or Y-Ae mAb (both mouse IgG2a) diluted in 50 l of normal saline every 2 days for 2 weeks. On day 13 to 15, mice were killed, the thymus and spleen were removed, and single-cell suspensions were prepared by using standard procedures for phenotypic analysis. 
Derivation of Dendritic Cells (DCs) from Bone Marrow (BM) Progenitors and Reprocessing of Antigens from Apoptotic B Cells Engulfed by
Immature DCs. DCs were generated in vitro from BM progenitors in complete RPMI medium 1640 supplemented with 1% recombinant granulocyte͞macrophage colony-stimulating factor as described (33, 35, 36) . Apoptotic B cells were derived by culturing splenocytes with 10 g͞ml LPS for 5 days in complete media. Apoptotic B cells were loaded on immature (day 5-6) DCs 24 hr before stimulation experiments as described (36, 37) . (Fig. 1A) . The original 1H3.1 hybrid also failed to respond (Fig. 1B) . Because 1H3.1 T cells react to 107 Tg (B6 I-E␣ Tg) B220 ϩ splenocytes which stain brighter for Y-Ae than I-Ab-Ep B220 ϩ cells (data not shown) and to minute amounts of the E␣52-68 peptide that do not generate a visualizable Y-Ae signal on B6 APCs (33), the lack of response to I-Ab-Ep APCs is not caused either by the expression of too many or of too few Y-Ae epitopes. We then considered anergy as a possible mechanism for the unresponsiveness of 1H3.1 T cells. Exogenous IL-2 had no effect on 1H3.1 T cells exposed to I-Ab-Ep splenocytes (data not shown). We then purified naive 1H3.1 TCR Tg CD4 ϩ T cells, exposed them to B6 or I-Ab-Ep purified B cells, repurified 1H3.1 T cells, and stimulated them with E␣52-68 and B6 APCs. Lack of costimulation was not an explanation for the very similar response in both cases (Fig. 1C) because LPS-induced I-Ab-Ep blasts, which express a high level of B7 molecules (data not shown), were not stimulatory ( 1D). Therefore, I-Ab-Ep APCs do not seem to induce anergy in naive 1H3.1 TCR Tg T cells.
Results

Encounter with APCs Expressing a Covalent Configuration of the E␣52-68͞I-
Finally, all of the I-Ab-Ep APC-responsive T hybrids we have tested (5͞5) were CD4-dependent; they did not respond to E␣52-68 loaded onto APCs with mutant I-A b ␤ chains unable to interact with CD4 (ref. 43 and data not shown). Such requirement suggests that they coengage CD4 when reacting to I-Ab-Ep APCs and, therefore, that the ability of the I-Ab-Ep protein to interact with CD4 is intact. Thus, the inability of 1H3.1 T cells to respond to I-Ab-Ep APCs probably does not result from a failure to establish a productive CD4-I-A b interaction. Collectively, the data indicate that the E␣52-68͞I-A b complex-specific 1H3.1 T cells are neither activated nor inactivated by encounter with I-Ab-Ep splenocytes. Theses results seem to be in contradiction with our earlier finding that adoptively transferred naive 1H3.1 TCR Tg T cells undergo a strong expansion into sublethally irradiated I-Ab-Ep hosts (25) . (Fig. 2 A) . In the periphery, a large number of V␤6 ϩ cells was detected in the spleen and lymph nodes and, as with normal 1H3.1 TCR Tg mice, these cells were mainly CD4 ϩ with only a few CD8 ϩ . The TCR-and CD4-expression levels were identical to those obser ved in normal 1H3.1 TCR Tg mice (Fig. 2 B) . Fig. 2) , most of them were CD44 (Fig. 5 A and B) . This reactivity is unequivocally specific because it is inhibited in a dose-dependent manner by Y-Ae but not Y17 (Fig. 5C) . Thus, 1H3.1 TCR Tg T cells that mature in vivo in the I-Ab-Ep thymus are not antagonized but rather remain naive and retain the capacity to specifically react to noncovalent configurations of the E␣52-68͞I-A b complex. cells before presentation on MHC class II molecules at the mature stage (36, 37, 55) . As expected, B6 (I-A bϩ ͞I-E␣ Ϫ ) DCs loaded with both I-Ab-Ep and B10.BR (I-A bϪ ͞I-E␣ ϩ ) but not with B6 apoptotic B cells were able to activate 1H3.1 TCR Tg T cells (Fig. 6A) . Surprisingly, I-Ab-Ep DCs were able to cause activation without loading. Such effect was observed for day 8-9 I-Ab-Ep BM cultures (i.e., mature DCs) but not for I-Ab-Ep cells from day 5-6 cultures (i.e., immature DCs; Fig. 6B ). Finally, mAb-blocking experiments showed that this activation is specific (Fig. 6C) . These results indicate that forcing E␣52-68͞I-A (48, 56) and shows that these cells are not antagonized.
CD4 (
The fine mechanism underlying this phenotype is unclear. We can formulate at least three hypotheses to explain it. First, the presence of the flexible linker could induce a subtle conformational change in the E␣52-68͞I-A b complex. Such an altered conformation could allow the activation of several specific T hybrids (but not of 1H3.1 T cells). Indeed, both N-and Cterminal extensions of the bound peptides have been shown to have an impact on the conformation of MHC class II molecules (57) . Such an effect may not be caused by a direct linker-TCR interference because the crystal structure of I-E k molecules with covalently attached peptides indicates that this linker does not protrude up from the complex (58) . Second, the conformation of E␣52-68͞I-A b complexes may be altered by the inappropriate environment where they are formed. In I-Ab-Ep mice, E␣52-68͞I-A b complexes are assembled in the endoplasmic reticulum (52) as opposed to the MIIC compartments; that is, in a significantly less-acidic context. One can imagine that in these two different cases, distinct conformations are possible, and that the 1H3.1 TCR is sensitive to such differences. Third, the activation of 1H3.1 T cells by the E␣52-68͞I-A b complex may depend on the corecognition of self-peptide͞I-A b complexes. This hypothesis (59) tries to explain the apparent contrast between the fact that few antigenic-peptide͞MHC complexes are required (0.03-0.1% of surface MHC class II molecules) for the activation of CD4 ϩ T cells (60, 61) and the results of a study of the APC-CD4 ϩ T cell interaction that reveals a large central domain occupied by supramolecular activation complexes (cSMACs) made only of TCRs contacting peptide͞MHC class II complexes and surrounded by a ring of interacting adhesive molecules (p-SMACs; ref. 62 ). In addition to antigenic peptide͞ MHC class II complexes, the large c-SMAC domain may incorporate self-peptide͞MHC complexes, which could participate in activation through a phenomenon discovered during a BIAcor (biomolecular interaction analysis) surface plasmon resonance analysis conducted at 37°C (63) . This study revealed a biphasic binding kinetics of the OT-1 TCR to its cognate ligand at physiological temperature. The kinetics fits best with a model where binding of a TCR to its ligand is followed by a dimerization event in which a second TCR binds to the existing TCR-peptide͞ MHC complex. This effect occurs only after an initial monomeric binding event, suggesting that a conformational change of the bound TCR triggers binding to unmodified TCRs. In an APC-T cell interaction context, TCRs recognizing agonist peptide͞MHC complexes may undergo a conformational change that allows their dimerization with unmodified TCRs that contact self-peptide͞self-MHC complexes. Then, this may allow coreceptor recruitment and lead to the aggregation seen in the c-SMAC domain upon T cell activation. Thus, recognition of the E␣52-68͞I-A b complex in the absence of self-peptide͞self-MHC complexes may preclude 1H3.1 TCR multimerization and consequently 1H3.1 T cell activation. Indeed, TCR conformational change (64) also may be involved in hypotheses 1 and 2; an altered conformation of E␣52-68͞I-A b complexes may still allow TCR-mediated delivery of a minimal signal but preclude conformational change in the 1H3.1 TCR and, therefore, the deletion͞activation of 1H3.1 T cells. Unlike I-Ab-Ep splenocytes and immature DCs, mature IAb-Ep DCs derived from BM progenitors were able to specifically stimulate 1H3.1 T cells. This is explained best by the reprocessing of E␣52-68͞I-A b complexes extracted from neighboring apoptotic cells. Upon endocytosis, the complexes can reach dense MIICs where the linker can be excised, and complexes carrying free E␣52-68 peptide and other peptides can be formed. Such reprocessing provides an explanation for the strong expansion of transferred 1H3.1 T cells into irradiated I-Ab-Ep hosts (25) . Sublethal irradiation of I-Ab-Ep mice certainly causes a massive apoptosis of B cells; such cells can be disposed of by phagocytic APCs that can reprocess the complexes.
In conclusion, our observations demonstrate that the E␣52-68͞I-A b complex-specific 1H3.1 T cells are not subjected to negative selection but, paradoxically, undergo positive selection in vivo in the I-Ab-Ep thymus where all of the I-A b molecules continuously present the covalently bound E␣52-68 peptide. Such positive selection directly relies on the conventional process of self-peptide͞self-MHC complex recognition. Finally, peripheral T cells from 1H3.1 TCR Tg I-Ab-Ep mice are not antagonized but rather display a naive phenotype and are specifically reactive to the E␣52-68 peptide bound to I-A b . Thus, the particular configuration of a bound agonist peptide expressed throughout the body is able to positively select and ensure the persistence of functional T cells specific for the same peptide.
